SCHEMBL9440237

SCHEMBL9440237

CCCCN1CCCCC1=S

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ RAB9A P51151 3/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ NOS1 P29475 2/20 0.33
▸ NOS2 P35228 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ THRB P10828 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ NR2F2 P24468 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ SIGMAR1 Q99720 2/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ ALOX5 P09917 2/20 0.33
▸ TSHR P16473 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ LTA4H P09960 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9440179 0.98 MEN1 (0.47) MEN1KMT2ARAB9AALDH1A1NOS1
SCHEMBL9440178 0.94 MEN1 (0.50) MEN1KMT2ARAB9AALDH1A1HPGD
SCHEMBL4143578 0.92 MEN1 (0.42) MEN1KMT2ARAB9AALDH1A1SMN1; SMN2
SCHEMBL9440202 0.90 MEN1 (0.41) MEN1KMT2ARAB9AALDH1A1SMN1; SMN2
SCHEMBL27064650 0.90 MEN1 (0.41) MEN1KMT2ARAB9AALDH1A1SMN1; SMN2
SCHEMBL4141905 0.90 MEN1 (0.41) MEN1KMT2ARAB9AALDH1A1SMN1; SMN2
SCHEMBL1956432 0.87 KMT2A (0.42) MEN1KMT2ARAB9AALDH1A1SMN1; SMN2
SCHEMBL10512029 0.87 HRH3 (0.47) MEN1KMT2AKDM4ELTA4H
SCHEMBL474116 0.86 ALOX5 (0.46) MEN1KMT2ARAB9AALDH1A1SMN1; SMN2
SCHEMBL9440188 0.86 ALOX5 (0.46) MEN1KMT2ARAB9AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0325616-B1 PENETRATION ENHANCERS FOR TRANSDERMAL DELIVERY OF SYSTEMIC AGENTS WHITBY RESEARCH INC (US) 1994-07-20 — — EP disclosed
US-5270346-A Penetration enhancers for transdermal delivery of systemic agents WHITBY RESEARCH, INC. (US) 1993-12-14 — — US disclosed
US-5256647-A Enhanced penetration of skin with antibiotic, bactericides WHITBY RESEARCH, INC. (US) 1993-10-26 — — US disclosed
US-5218113-A To enhance the penetration of physiologically active agent through the skin or other membrane WHITBY RESEARCH, INC. (US) 1993-06-08 — — US disclosed
EP-0257063-B1 COMPOSITIONS COMPRISING 1-SUBSTITUTED AZACYCLOALKANES AND THEIR USES WHITBY RESEARCH, Inc. (US) 1992-06-17 — — EP disclosed
US-4992422-A Enhanced penetration of skin, membranes WHITBY RESEARCH, INC. (US) 1991-02-12 — — US disclosed
EP-0325616-A4 PENETRATION ENHANCERS FOR TRANSDERMAL DELIVERY OF SYSTEMIC AGENTS. NELSON RES & DEV COMPANY (US) 1989-12-12 — — EP disclosed
EP-0325616-A1 PENETRATION ENHANCERS FOR TRANSDERMAL DELIVERY OF SYSTEMIC AGENTS. NELSON RES & DEV (US) 1989-08-02 — — EP disclosed
WO-1988002626-A1 PENETRATION ENHANCERS FOR TRANSDERMAL DELIVERY OF SYSTEMIC AGENTS NELSON RESEARCH AND DEVELOPMENT COMPANY (US) 1988-04-21 — — WO disclosed
Send feedback